Massachusetts sues opioid maker, executives over drug crisis

June 12, 2018 by Alanna Durkin Richer
Massachusetts sues opioid maker, executives over drug crisis
In this June 1, 2018 file photo, Massachusetts Attorney General Maura Healey speaks at the 2018 Massachusetts Democratic Party Convention in Worcester, Mass. Massachusetts has sued the maker of OxyContin over the deadly opioid crisis and has become the first state to also target the company's executives. Healey announced the lawsuit Tuesday, June 12 against Purdue Pharma and 16 current and former executives and board members, including CEO Craig Landau. (AP Photo/Elise Amendola, File)

Massachusetts sued the maker of prescription opioid painkiller OxyContin and its executives on Tuesday, accusing the company of spinning a "web of illegal deceit" to fuel the deadly drug abuse crisis while boosting profits.

Purdue Pharma is already defending lawsuits from several states and local governments, but Massachusetts is the first state to personally name the company's executives in a complaint, Attorney General Maura Healey said. It names 16 current and former executives and board members, including CEO Craig Landau and members of the Sackler family, which owns Purdue.

The lawsuit alleges Purdue deceived patients and doctors about the risks of opioids, pushed prescribers to keep patients on the drugs longer and aggressively targeted vulnerable populations, like the elderly and veterans.

"Their strategy was simple: The more drugs they sold, the more money they made, and the more people died," Healey told reporters.

Purdue, based in Stamford, Connecticut, didn't immediately respond to a request for comment from The Associated Press, but told The Boston Globe it "vigorously" denies the allegations.

"We share the 's concern about the opioid crisis," the company told the newspaper in a statement." We are disappointed, however, that in the midst of good faith negotiations with many states, the Commonwealth has decided to pursue a costly and protracted litigation process. We will continue to work collaboratively with the states toward bringing meaningful solutions," it said.

Purdue agreed to pay $19.5 million in 2007, but did not admit wrongdoing, to settle lawsuits with 26 states—including Massachusetts— and the District of Columbia after being accused of aggressively marketing OxyContin to doctors while downplaying the risk of addiction.

Massachusetts' lawsuit, which was filed in the Suffolk Superior Court, alleges that Purdue's leadership encouraged the company's "deadly misconduct" while lining their pockets. The sale of more than 70 million doses of in the state over the last decade brought in more than $500 million for the company, Healey says.

"It was Purdue's executives who led and directed this illegal business model, leading to addiction and deception to enrich a few while leaving a path of devastation and destruction in its wake," she said.

Explore further: 6 US states accuse opioid maker Purdue of fueling overdoses

Related Stories

6 US states accuse opioid maker Purdue of fueling overdoses

May 15, 2018
Six U.S. states on Tuesday sued the maker of the opioid OxyContin of using deceptive marketing to boost drug sales that fueled opioid overdose deaths.

US states sue OxyContin maker over opioid crisis

May 16, 2018
Six US states sued OxyContin maker Purdue Pharma on Tuesday for alleged deceptive trade practices related to its marketing of the opioid painkiller.

South Carolina sues drug manufacturer over opioid crisis

August 15, 2017
South Carolina has become the latest state to accuse a drug manufacturer of exacerbating its opioid drug crisis by using deceptive marketing, with the state's top prosecutor suing the maker of OxyContin.

Alabama files lawsuit against opioid manufacturer

February 6, 2018
Alabama on Tuesday filed a lawsuit against the manufacturer of OxyContin and other opioids, becoming the latest state seeking to hold drug companies accountable for an addiction epidemic.

OxyContin maker will stop promoting opioids to doctors

February 10, 2018
The maker of the powerful painkiller OxyContin said it will stop marketing opioid drugs to doctors, a surprise reversal following lawsuits that blamed the company for helping trigger the current drug abuse epidemic.

US city sues maker of painkiller OxyContin

January 20, 2017
A small US city on Thursday filed a lawsuit against Purdue Pharma, the maker of the pain reliever OxyContin, accusing the company of helping fuel an opioid crisis that has devastated the town.

Recommended for you

Medicating distress: Risky sedative prescriptions for older adults vary widely

October 18, 2018
Despite years of warnings that older adults shouldn't take sedative drugs that put them at risk of injury and death, a new study reveals how many primary care doctors are still prescribing them, how often, and exactly where.

Medical management of opioid-induced constipation differs from other forms of condition

October 17, 2018
Traditional laxatives are recommended as first-line agents to treat patients with a confirmed diagnosis of opioid-induced constipation (OIC), according to a new guideline from the American Gastroenterological Association ...

Research assesses geographic distribution of new antibiotics following market introduction

October 16, 2018
There is a growing need for new antibiotics to help combat the looming threat of antimicrobial resistance. According to a new study conducted by researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) with ...

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

Do price spikes on some generic drugs indicate problems in the market?

October 1, 2018
A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.